Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection;Esteatose e esteatohepatite não-alcoólica nos pacientes com hepatite crônica pelo vírus da hepatite C

Arquivos de Gastroenterologia

Volumn 43, Issue 4, 2006, Pages 265-268

  Coral, Gabriela ^a,b   De Mattos, Angelo Alves ^a   De Mattos, Ângelo Zambam ^a   Dos Santos, Diogo Edele ^a  

^a Irmandade Santa Casa de Misericórdia de Porto Alegre   (Brazil)

^b NONE   (Brazil)

Author keywords

Fatty liver; Hepatitis C, chronic

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREVALENCE; SCORING SYSTEM; STEATOSIS;

ADULT; AGED; BIOPSY; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; FATTY LIVER; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 34147130101     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032006000400004     Document Type: Article

References (32)

1. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001;33:1358-64.
2. American Diabetes Association. Clinical practice recommendations 2000. Diabetes Care. 2000;23 (Suppl):1-8.
3. Asselah T, Boyer N, Guimont M-C, Cazals-Hatem D, Tubach F, Nahon K, Daikha H, Vidaud D, Martinot M, Vidaud M, Degott C, Valla D, Marcellin P. Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut. 2003;52:1638-43.
4. Bach N, Thung SN, Schaffner. The histological features of chronic hepatitis C and autoimmune chronic hepatitis a comparative analysis. Hepatology. 1992;15:572-7.
5. Brunt EM, Janney C, Di Bisceglie A, Neuschwander-Tetri B, Bacon B. Nonalcoholic steatohepatitis: a proposal for grading and staging the histologic lesions. Am J Gastroenterol. 1999;94:2467-74.
6. Castéra L, Hézode C, Roudot-Thoraval F, Bastie A, Zafrani ES, Pawlotsky J, Dhumeaux D. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut. 2003;52:288-92.
7. Castéra L, Hézode C, Roudot-Thoraval F, Lonjon I, Zafrani E-S, Pawlotsky J-M, Dhumeaux D. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis. Gut. 2004;53:420-4.
8. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol. 1998;29:198-206.
9. Diehl AM. Insulin resistence and steatosis in hepatitis C virus infection. Gut. 2005;54:903-6.
10. Fartoux L, Poujol-Robert A, Guechout J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut. 2005;54:1003-8.
11. Friedenberg F, Pungpapong S, Zaeri N, Braitman L. The impact of diabetes and obesity on liver histology in patients with hepatitis C. Diabetes Obes Metab. 2003;5:150-5.
12. Gayotto LCC, Comitê SBP/SBH. Visão histórica e consenso nacional sobre a classificação das hepatites crônicas. Projeto do Clube de Patologia Hepática da Sociedade Brasileira de Patologia aprovado pela Sociedade Brasileira de Hepatologia. GED Gastroenterol Endosc Dig. 2000;19:137-40.
13. Gayotto LCC. Esteato-hepatite não-alcoólica. In: Gayotto LCC, Alves VAF, editores. Doenças do fígado e das vias biliares. São Paulo: Atheneu; 2001. cap.35.
14. Gayotto LCC, Alves VAF. Patologia das hepatites crônicas. In: Gayotto LCC, Alves VAF, editores. Doenças do fígado e das vias biliares. São Paulo: Atheneu; 2001. cap.49.
15. Gordom A, McLean C, Pedersen J, Bailey M, Roberts S. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol. 2005;43:38-44.
16. Halfon P, Ouzan D, Cattan L, Cacoub P. The diagnostic tools of hepatitis C virus infections. Presse Med. 2004;33:538-41.
17. Hwang SJ, Luo J, Chu C, Lai C, Lu C, Tsay S, Wu J, Chang F, Lee S. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol. 2001;16;190-5.
18. Kumar D, Farrell G, Fung C, George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes reversal of hepatic steatosis after sustained therapeutic response. Hepatology. 2002;36:1266-72.
19. Lerat H, Honda M, Beard M, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao S-Y, Weinman S, Lemon S. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology. 2002;122:352-65.
20. Liu CJ, Jeng YM, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C. Antivir Ther. 2005;10:405-15.
21. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsusumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Todoroki T, Kimura S, Koike K. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001;61:4365-70.
22. Neuschwander-Tetri B, Caldwell S. Nonalcoholic steatohepatitis. Summary of an AASLD single topic conference. Hepatology. 2003;37:1202-19.
23. Okuda M, Li K, Beard M, Showalter L, Scholle F, Lemon S, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002;122:366-75.
24. Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, Younossi Z, Albrecht J. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology. 2003;38:75-85.
25. Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male P-J, Giostra E, Carlotto A, Bozzola L, Smedile A, Negro F. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut. 2004;53:406-12.
26. Sanyal AJ. Non-alcoholic fatty liver disease and hepatitis C - risk factors and clinical implications. Aliment Pharmacol Ther. 2005;22 (suppl 2):48-51.
27. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Duscheiko GM. The patology of hepatitis C. Hepatology. 1992;15:567-71.
28. Solis-Herruzo JA, Perez-Carreras M, Fernandez-Vazquez I, Garfia C, Bernardos E, Castellano G, Colina F. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C. Am J Gastroenterol. 2005;100:1091-8.
29. Wanless IR, Lenz JS. Fatty liver hepatitis (steatohepatitis) and obesity an autopsy study with analysis of risk factors. Hepatology. 1990;12:1106-10.
30. Westin J, Nordlinder H, Lagging M, Norkrans G, Wejstal R. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol. 2002;37:837-42.
31. Wyatt J, Baker H, Prasad P, Gong YY, Millson C. Steatosis and fibrosis in patients with chronic hepatitis C. J Clin Pathol. 2004;57:402-6.
32. Younossi ZM, McCullough A, Ong JP, Barnes DS, Post A, Tavill A, Brigman D, Martin L, Assmann J, Gramlich T, Mullen K, O'Shea R, Cartey W, Ferguson R. Obesity and non-alcoholic fatty liver disease in chronic hepatitis C. J Clin Gastroenterol. 2004;38:705-9.